Implantable Loop Recorders in Post-atrial Fibrillation (AF) Ablation: RPAF-A

Completed

Conditions studied: Atrial Fibrillation

In brief

This is a randomized pilot study, of post pulmonary vein isolation (PVI) patients to determine the clinical utility of the Implantable Loop Recorder. These type of patients either are monitored with weekly transtelephonic monitoring (TTM) or implantable loop recorder (ILR). The Medtronic Reveal XT loop recorder will be implanted at the time of the PVI or at the 3-4 month PVI follow-up visit and patient care will be managed based on randomization to a blinded or unblinded group. Outcome measures will be compared to aid in decision making regarding anticoagulation and overall post ablation clinical management.

Key facts

Study ID

NCT01061125

Run by

The Cleveland Clinic

People needed

68

Starts

2010-01-01

Expected to finish

2016-10-01

Last updated by the study team

2017-02-10

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• atrial fibrillation
• Chads score > or equal to 1

You may not qualify if…

• contraindication for ILR
• life expectancy less an 12 months
• pregnant women
• existing cardiac rhythm management (CRM) device

Where it is running

• Cleveland Clinic — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.